scispace - formally typeset
I

Ivan Rios-Mondragon

Researcher at University of Bergen

Publications -  7
Citations -  138

Ivan Rios-Mondragon is an academic researcher from University of Bergen. The author has contributed to research in topics: Medicine & DNA methylation. The author has an hindex of 5, co-authored 5 publications receiving 66 citations.

Papers
More filters
Journal ArticleDOI

Microfluidics for studying metastatic patterns of lung cancer

TL;DR: The first comprehensive overview of the microfluidic systems used as innovative tools in the studies of lung cancer metastasis including single cancer cell analysis, endothelial transmigration, distant niches migration and finally neoangiogenesis is presented.
Journal ArticleDOI

Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives.

TL;DR: An overview of ongoing clinical trials focusing on combination therapies employing epi-drugs for breast cancer treatment is provided and the latest nano-based targeted delivery approaches forEpigenome modulation are summarized, highlighting the current limitations and obstacles associated with applying these experimental strategies in the clinics.
Journal ArticleDOI

Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.

TL;DR: It is reported that THSer(P)-31 co-distributes with the Golgi complex and synaptic-like vesicles in rat and human dopaminergic cells and indicates that Ser-31 phosphorylation may regulate TH subcellular localization by enabling its transport along microtubules, notably toward the projection terminals.
Journal ArticleDOI

Novel microscopy-based screening method reveals regulators of contact-dependent intercellular transfer

TL;DR: The authors' data indicates that cellular protrusions and tubular recycling endosomes are important for codeIT, and an siRNA-based screening using this method revealed the involvement of several myosins and small GTPases as codeIT regulators.